BUCCHI, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 7.075
NA - Nord America 5.128
AS - Asia 4.109
SA - Sud America 305
AF - Africa 70
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.718
Nazione #
US - Stati Uniti d'America 5.011
DE - Germania 2.599
GB - Regno Unito 1.398
CN - Cina 1.263
SG - Singapore 1.224
IT - Italia 1.195
SE - Svezia 583
HK - Hong Kong 461
RU - Federazione Russa 336
VN - Vietnam 222
BD - Bangladesh 220
BR - Brasile 218
FR - Francia 205
IN - India 174
TR - Turchia 151
NL - Olanda 138
KR - Corea 133
IE - Irlanda 126
FI - Finlandia 115
UA - Ucraina 111
DK - Danimarca 72
JP - Giappone 69
CA - Canada 68
ID - Indonesia 64
EU - Europa 52
PL - Polonia 39
AR - Argentina 32
BE - Belgio 27
MX - Messico 23
AT - Austria 22
CI - Costa d'Avorio 22
CH - Svizzera 21
NO - Norvegia 20
AU - Australia 19
CO - Colombia 18
PK - Pakistan 18
TW - Taiwan 17
ZA - Sudafrica 15
ES - Italia 14
PH - Filippine 14
IQ - Iraq 13
CL - Cile 11
GR - Grecia 11
EC - Ecuador 9
CZ - Repubblica Ceca 8
MY - Malesia 8
CY - Cipro 7
NP - Nepal 7
NZ - Nuova Zelanda 7
RO - Romania 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 5
LU - Lussemburgo 5
MA - Marocco 5
TH - Thailandia 5
TN - Tunisia 5
UY - Uruguay 5
GE - Georgia 4
IR - Iran 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
PE - Perù 3
PT - Portogallo 3
SI - Slovenia 3
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
PY - Paraguay 2
SC - Seychelles 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BT - Bhutan 1
CV - Capo Verde 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GL - Groenlandia 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
Totale 16.748
Città #
Hanover 2.199
Southend 1.271
Singapore 698
Milan 619
Ashburn 505
Chandler 452
Hong Kong 425
San Jose 341
Dallas 331
Beijing 258
Seattle 229
Wilmington 179
Council Bluffs 178
Fairfield 158
Princeton 148
Los Angeles 139
Dublin 124
Ann Arbor 102
Boardman 98
Frankfurt am Main 96
Woodbridge 94
New York 84
The Dalles 84
Ho Chi Minh City 80
Dearborn 78
Santa Clara 78
Lauterbourg 75
Bengaluru 74
Jacksonville 70
Hefei 67
Houston 67
Redmond 66
Mountain View 65
Nanjing 65
Hanoi 63
Guangzhou 58
Cambridge 55
Moscow 55
Shanghai 52
Buffalo 49
Munich 46
Sakarya 45
Rome 44
Shenyang 44
Des Moines 43
Jakarta 42
Phoenix 41
Columbus 40
Tokyo 40
Warsaw 39
Serra 37
Helsinki 36
Redwood City 33
Chicago 31
Cangzhou 28
São Paulo 26
Seoul 25
Jinan 24
Brussels 23
Abidjan 22
Andover 22
Berlin 22
Nuremberg 22
Tianjin 22
London 21
Toronto 20
Eitensheim 19
Turin 19
San Diego 18
Changsha 17
Hangzhou 17
Shenzhen 17
Bogotá 15
Fuzhou 15
Istanbul 15
Kunming 15
Roxbury 15
Sunnyvale 15
Vienna 15
Zhengzhou 15
Atlanta 14
Bitonto 14
Brooklyn 14
Grafing 14
Medford 14
Washington 14
Da Nang 13
Nanchang 13
Amsterdam 12
Genoa 12
Hebei 12
Jiaxing 12
Somerville 12
Turku 12
Brescia 11
Johannesburg 11
Montreal 11
Taipei 11
Ankara 10
Costa Mesa 10
Totale 11.240
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 675
A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia 597
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 555
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate 511
Mammalian γ2 AMPK regulates intrinsic heart rate 504
Embryonic stem cell-derived CD166+ precursors develop into fully functional sinoatrial-like cells 483
Dual role of miR-1 in the development and function of sinoatrial cells 462
A detailed characterization of the hyperpolarization-activated "funny" current (If) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity 456
Cell-specific dynamic clamp analysis of the role of funny If current in cardiac pacemaking 428
Current understanding of the pathophysiological mechanisms responsible for inappropriate sinus tachycardia : role of the If “funny” current 427
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 405
Rate-adapted dynamic-clamp of the funny current in sinoatrial pacemaker cells 383
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 357
INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model 344
I-f modulation: perspectives in clinical medicine 295
A synthetic peptide that prevents cAMP regulation in mammalian hyperpolarization-activated cyclic nucleotide-gated (HCN) channels 292
The funny current: Even funnier than 40 years ago. Uncanonical expression and roles of {HCN}/f channels all over the body 266
Identification of the Molecular Site of Ivabradine Binding to HCN4 Channels 265
Lack of the transcription factor Nfix causes tachycardia in mice sinus node and rats neonatal cardiomyocytes 264
C terminus-mediated control of voltage and cAMP gating of hyperpolarization-activated cyclic nucleotide-gated channels 256
Exercise training reduces resting heart rate via downregulation of the funny channel HCN4 254
Regulation of sinus node pacemaking and atrioventricular node conduction by HCN channels in health and disease 254
Functional Characterization of a Novel Scn5a Mutation Associated With the Brugada Syndrome 249
Developing Synthetic Peptides to Regulate Native HCN Channels 246
Age-related changes in cardiac autonomic modulation and heart rate variability in mice 237
f-channel dependent modulation of cardiac SAN activity in the presence and absence of ryanodine 232
Striatin knock out induces a gain of function of INa and impaired Ca2+ handling in mESC‐derived cardiomyocytes 218
Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4 211
HCN Channels and Cardiac Pacemaking 205
PITX2 gain-of-function mutation associated with atrial fibrillation alters mitochondrial activity in human iPSC atrial-like cardiomyocytes 202
Cyclic dinucleotides bind the C-linker of HCN4 to control channel cAMP responsiveness 190
Funny current and cardiac rhythm: insights from HCN knockout and transgenic mouse models 187
Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels 182
Current-dependent block of rabbit sino-atrial node I-f channels by ivabradine 175
f-channel dependent modulation of cardiac SAN activity in the presence and absence of ryanodine 175
Modulation of rate by autonomic agonists in SAN cells involves changes in diastolic depolarization and the pacemaker current 174
Autonomic rate modulation in san cells involves changes in diastolic depolarization and the i(f) current 173
Integrated allosteric model of voltage gating of HCN channels 172
Functional comparison of HCN isoforms expressed in ventricular and HEK 293 cells 170
Physiology and pharmacology of the cardiac pacemaker ("funny") current 169
Heart rate reduction via selective "funny" channel blockers 166
Caveolin-3 and Caveolin-1 Interaction Decreases Channel Dysfunction Due to Caveolin-3 Mutations 165
Identification of residues involved in binding of ivabradine to hHCN4 channels 165
The If current not the SR calcium release, mediates modulation of cardiac pacemaker rate 161
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 158
I canali pacemaker HCN4 hanno un ruolo fondamentale nel mantenimento della normale frequenza cardiaca e nella conduzione AV 158
Allosteric voltage-dependent gating of HCN channels 157
The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction 151
The funny pacemaker current 148
The cardiac pacemaker current 148
Chinese natural compound decreases pacemaking of rabbit cardiac sinoatrial cells by targeting second messenger regulation of f-channels 145
Assessment of the functional relevance of the If current in AVN cells using a cardiac-specific and inducible HCN4 KO mouse model 142
Physiology and pharmacology of cardiac pacemakers (“funny”) current 140
I(f)-dependent modulation of pacemaker rate mediated by cAMP in the presence of ryanodine in rabbit sino-atrial node cells 137
Assessment of the functional relevance of the pacemaker If current using a cardiac-specific and inducible HCN4 KO mouse model 135
Kinetic properties of HCN channels 134
Ivabradine block of If is current dependent 133
If and sinoatrial node pacemaking 133
Identification of residues of the hHCN4 channel involved in the binding of the heart rate reducing agent ivabradine 130
Anthocyanins confer cardioprotection against Doxorubicin by modulating the AMPK-SIRT1-p53 pathway 128
Autonomic rate control involves f-channels-mediated modulation of the early diastolic depolarization 128
Kinetic properties of rHCN1 and rHCN4 coexpression 121
"Funny" pacemaker current 119
Regulation of Gating and rundown of HCN hyperpolarization-activated channels by exogenous and endogenous PIP2 117
The HCN4 pacemaker channel is required to mantain proper heart rate in mice 116
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I-f blockade 116
Assessing the mechanism of action of rate modulating agents by measuring specific action potential parameters 115
Molecular cloning of the SAN Na channel 114
Expression of skeletal but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium 114
Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker 112
Screening for mutations of the pacemaker (hHCN4) gene in patients affected by rhtyhm disturbances 108
HCN residues critically involved in drug binding are important determinant of channel kinetic properties 106
Toward a better understanding of HCN4 inhibition by the heart rate reducing agent ivabradine 103
Modulation of cyclic nucleotide-regulated HCN channels by PIP2 and receptors coupled to phospholipase C 102
Inhibitory action of ivabradine on hHCN4 channel 100
In vitro characterization of HCN channel kinetics and frequency dependence in myocytes predicts biological pacemaker functionality 100
Mechanism of HCN1 and HCN4 block by ivabradine 95
f/HCN channels : From a tiny current controlling cardiac pacemaking to a pleiotropic current all over the body 85
Hypokalemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation 81
Purple Corn Extract Prevents Doxo‐Induced Cardiotoxicity by Counteracting AMPK Activation and p53 Acetylation in HL‐1 and Primary Cardiomyocytes 73
Camizestrant-induced heart rate reduction is mediated via a sinoatrial node pacemaker channel mechanism 35
NOD-1 activation increases the spontaneous activity and the I(f) current of murine sinoatrial node cells 12
Totale 17.406
Categoria #
all - tutte 43.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/20223.312 57 72 96 340 344 428 361 335 356 393 285 245
2022/20231.321 207 165 119 144 142 207 41 64 126 18 55 33
2023/2024912 18 64 53 51 186 55 41 48 32 46 157 161
2024/20252.112 116 209 58 199 130 105 71 260 109 203 225 427
2025/20264.792 429 287 602 341 485 366 600 219 495 366 478 124
Totale 17.406